We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Chiral Technologies, Inc. Acquires Arbor Biosciences – Increasing Their Portfolio for the Biopharma Industry

Product News   Jan 16, 2019

 
Chiral Technologies, Inc. Acquires Arbor Biosciences – Increasing Their Portfolio for the Biopharma Industry
FURTHER INFORMATION
 
 
 

Related Product News

Supporting Reduction of Anemia in Developing Regions in South America

Product News

A new symposium highlights the use of EKF’s Hemo Control hemoglobin analyzer in the fight to reduce chronic child malnutrition in South America.

READ MORE

Additional Funding Awarded for Regenerative Cartilage Therapy Development

Product News

Mogrify has announced that it has secured $1.1M of additional funding from SBRI Healthcare to assess its regenerative cartilage therapy.

READ MORE

TMAC Cancer Therapy Platform Demonstrates Successful Proof-of-concept

Product News

Avacta, the developer of Affimer® biotherapeutics and reagents, has announced that it has demonstrated initial proof-of-concept for its proprietary new class of drug conjugate.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cell Science Diagnostics Drug Discovery Genomics Research Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE